Pharmacy

Snehal Doshi. Vice President of Pharmacy Services at WellStar Health System (Marietta, Ga.). During Mr. Doshi’s tenure, WellStar Health System received the Georgia Hospitals Association’s Quality and Patient Safety Award. Before joining WellStar, Mr. Doshi was president of prescribed minimum benefits…

Bloomfield, Conn.-based Cigna dropped coverage for Mylan's EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative according to the payer's prescription drug list changes, which were effective Jan. 7. 

In a recent press release, Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the launch of Biosimilars Clarified (www.merckclarifiesbiosimilars.com), a new educational website for patients, caregivers and the healthcare community that is designed to provide clear,…

Ivyland, PA, Fall 2016 – Dispensing oral narcotics and medications of abusive potentiality requires stringent controls. Medications must be rigidly accounted for and protected throughout the hospital dispensing system.

Health insurer Independence Blue Cross will cover Belgium-based MDxHealth's prostate cancer test.

Health insurer Blue Cross Blue Shield of Nebraska will cover minimally invasive sacroiliac joint fusion using San Jose, Calif.-based SI Bone's device indicated for fusion for certain disorders of the joint.

Minnetonka, Minn.-based UnitedHealth Group made a deal with Kalamazoo, Mich.-based medical technology producer Medtronic in May, which effectively decreased the number of in-network portable insulin pumps it offers members from nine to three, The New York Times reported.

Most health insurers would like to pay for many expensive medications based on their ability to improve patient outcomes, according to a survey by health consulting firm Avalere Health, STAT reported.

Woonsocket, R.I.-based CVS Health outlined five strategies the company deployed in its retail pharmacy services for a consumer-driven approach to healthcare, according to DrugStoreNews.

 The market for laparoscopy devices, as reported by Transparency Market Research, is projected to reach $13,152.9 million in 2018, a substantial increase from its worth of $6,968 million in 2011.